Participate in a clinical trial for an FDA-approved narcolepsy drug
Aaron Charlton2024-05-24T13:29:40-07:00The Treatment: XYWAV is an FDA-approved treatment for narcolepsy and Idiopathic Hypersomnia (IH). Study Aims: Assess the safety and efficacy of the treatment on sleepiness, polysomnography measurements (eg, sleep stage transitions, sleep patterns, and sleep quality), daytime and nighttime symptoms, pharmacokinetics (in narcolepsy), and patient-reported